Robert Blazej - Profile and Investment Details

Investor Profile

Robert Blazej is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads, SiteOne Therapeutics, Alector, Pionyr Immunotherapeutics, Nitrome Biosciences, Asilomar Bio, ViewPoint Therapeutics, Tangible Science, Principia Biopharma, Circle Pharma, Atreca, Zephyrus Biosciences, Cell Design Labs, Redwood Bioscience, Glycomine, Effector Therapeutics, GraphWear Technologies, Wild Type, Vivace Therapeutics. Over time, Robert Blazej has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Robert Blazej is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Women Led, Biotech, Medical Device, Healthcare, Biotechnology, Natural Resources, Genomics, AgTech, Food and Beverage, Agriculture, Farming, Nanotechnology, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Robert Blazej, as their portfolio suggests a familiarity and interest in this area.

Understanding Robert Blazej’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.